AnaptysBio is a clinical stage biotechnology company developing antibody product candidates. Etokimab, the company's anti-IL-33 antibody drug candidate, inhibits the activity of the interleukin-33 cytokine that is applicable to the treatment of atopic inflammatory disorders, such as moderate-to-severe atopic dermatitis, eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and potentially other allergic conditions. ANB019 inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases including generalized pustular psoriasis and palmoplantar pustulosis. The company's wholly-owned pipeline includes anti-inflammatory checkpoint receptor modulator antibodies.

Anixa Biosciences is a biotechnology company focused on using the body's immune system to diagnose, treat and prevent cancer. The company's subsidiary, Anixa Diagnostics Corporation, develops Cchek?, a platform for non-invasive blood tests for the early detection of cancer. The company's subsidiary, Certainty Therapeutics, Inc., develops immuno-therapy drugs against cancer. The company has focused on the development of a treatment for ovarian cancer. The company is also engaged in limited patent licensing activities in the area of encrypted audio/video conference calling.

Friedman Industries manufactures and processes steel products and operates in two segments; coil products and tubular products. The coil product segment consists of the operation of hot-roll coil processing facilities. This segment sells its prime grade inventory under the Friedman Industries name but also maintains an inventory of non-standard coil products, consisting of mill secondary and excess prime coils. The tubular product segment consists of the company's Texas Tubular Products division (TTP), which operates electric resistance welded pipe mills. TTP has a pipe finishing facility that threads and couples oil country tubular goods and performs other services in the pipe finishing process.

JELD-WEN Holding is a holding company. Through its subsidiaries, the company is a door and window manufacturer. The company designs, produces, and distributes a range of interior and exterior doors, wood, vinyl, and aluminum windows, and related products for use in the construction and repair and remodel of residential homes and, to a lesser extent, non-residential buildings. The company markets its products under the JELD-WEN brand, along with several brands such as Swedoor and DANA in Europe and Corinthian, Stegbar, and Trend in Australia. The company's customers include wholesale distributors and retailers as well as individual contractors and consumers. The company has three segments: North America, Europe, and Australasia.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Tile Shop Holdings is a holding company. Through its subsidiaries, the company is a retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the U.S. The company provides a range of natural stone and man-made tile products, sourced directly from its suppliers. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, and metal tiles. The company's accessories, including trim pieces, mosaics, pencils, listellos, and other products. The company also provides a range of setting and maintenance materials, such as thinset, grout, sealers, and accessories.

Urban One and its subsidiaries is an urban-oriented, multi-media company that primarily targets African-American and urban consumers. The company's principal business is its radio broadcasting franchise. The company has four reportable segments: radio broadcasting, which includes the company's broadcast operations; Reach Media, which includes the operations of Tom Joyner Morning Show and related activities and operations of other syndicated shows; digital, which consist of the company's online business, including the operations of Interactive One, as well as the digital components of the company's other reportable segments; and cable television, which consists of TV One, LLC operations.